Welcome to the data submission page of OvirusTdb

We aim to make OvirusTdb - a single platform of the available information related to the oncolytic viruses used in cancer therapeutics and we appreciate your contribution for the same.

Submit Information on Oncloytic Virus
*Name of virus (e.g.* Adenovirus ):**
*Strain of virus (e.g.* Wild/Mutant ):**
*Genome type (e.g.* DNA/RNA):**
*Family of virus (e.g.* Adenoviridae ):**
*Modification in viral genome (e.g.* addition/deletion in genome ):**
*Virus in combination with any chemotherapeutics (e.g.* Virus with any drug(ABT-737)/radiation ):**
*Immune gene integration (e.g.* IL-2, IL-4 integrated with genome ):**
*Source of cell line (e.g.* ATCC, NCI etc. ):**
*Cell line origin (e.g.* Human breast cancer cell line ):**
*Cell line name (e.g.* MCF-7 ):**
*Concentration of cell line (e.g.* 1000 cells/well ):**
*Assay (e.g.* MTT assay ):**
*Concentration of virus (In-vitro) (e.g.* 1 MOI ):**
*cell death/survival (In-vitro) (e.g.* 10% cell death ):**
*Model Organism (e.g.* Balb/c ):**
*Concentration of virus (In-vivo) (e.g.* 1 MOI ):**
*cell death/survival (In-vivo) (e.g.* Tumor size reduced by 4 folds ):**
*Mode of delivery of virus in organism (e.g.* Intravenous ):**
*Any pathway activation seen (e.g.* Apoptotic pathway indution ):**
*Immunogenic effect (e.g.* IL-2, TNF-alpha activation ):**
PMID (PubMed identification number)/Patent:

Additional Information
Submitter's name:
Email Address :
Mailing Address (Optional) :
Comment or Suggestion: